Mirabegron and Atrial fibrillation/flutter - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation/flutter is reported as a side effect among people who take Mirabegron (mirabegron), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Tamsulosin, and have Hypertonic bladder.

The phase IV clinical study analyzes which people have Atrial fibrillation/flutter when taking Mirabegron. It is created by eHealthMe based on reports of 5,378 people who have side effects when taking Mirabegron from the FDA, and is updated regularly.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,366 drugs and 3,840 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

On Jul, 05, 2026

5,378 people reported to have side effects when taking Mirabegron.
Among them, 60 people (1.12%) have Atrial fibrillation/flutter.

Could Mirabegron cause Atrial fibrillation/flutter?

Among these 60 people:

How long have people been on Mirabegron when they have Atrial fibrillation/flutter? *

What is the gender of people who have Atrial fibrillation/flutter when taking Mirabegron? *

female: 43.1 %
male: 56.9 %

What is the age of people who have Atrial fibrillation/flutter when taking Mirabegron? *

What are other drugs people take besides Mirabegron? *

What are other side effects people have besides Atrial fibrillation/flutter? *

Arrhythmias (irregular heartbeat): 10 people, 16.67%
Pneumonia: 8 people, 13.33%
Chest Pain: 8 people, 13.33%
Dyspnea (difficult or laboured breathing): 7 people, 11.67%
Fatigue (feeling of tiredness): 6 people, 10.00%
Fall: 5 people, 8.33%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 4 people, 6.67%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 5.00%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 3 people, 5.00%
Nutritional Condition Abnormal: 3 people, 5.00%

What are the existing conditions these people have? *

Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 24 people, 40.00%
High Blood Pressure: 8 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 11.67%
Parkinson's Disease: 6 people, 10.00%
Type 2 Diabetes: 5 people, 8.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 8.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 8.33%
High Blood Cholesterol: 5 people, 8.33%
Osteoporosis (bones weak and more likely to break): 4 people, 6.67%
Enlarged Prostate: 4 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Mirabegron and have Atrial fibrillation/flutter?

- Check whether Atrial fibrillation/flutter is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mirabegron:

Mirabegron (5,414 reports)

Browse all side effects of Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (2,366 drugs)

Browse all the conditions that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (3,840 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirabegron (the active ingredients of Mirabegron) and Mirabegron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.